After transfection of BMCs using BCR-ABL1 with IL-3/IL-6/SCF, 14.6% of RalARosa26-Tg/+ CML-like cells retained the LSK phenotype. This evidence concerns the gene IL3 and chronic myelogenous leukemia, BCR-ABL1 positive.